A New York jury awarded $8 million to plaintiff 72-year-old Shirley Boles from Fort Walton, Florida who claimed Merck’s osteoporosis drug Fosamax destroyed her jawbone causing serious pain and disability. The jury concluded that Fosamax was “unreasonably dangerous due to defective design, and that its defective design was a legal cause of Mrs. Boles’ injury.”… Read more
2Million2Many
Agency
alendronate
almonds
Amgen
anabolic
Anorexia
aromatase inhibitors
ASBMR
Atypical femur fractures
Atypical Fractures
Awareness
beans
Binosto
Bisphosphonates
bok choy
Bone
Bone Connection
Bone Density
Bone Health
Bone Loss
Bone mass measurement
Boniva
Bread
breast cancer
breast cancer month
Breastfeeding
Calcitonin
Calcium
CDC
Celebrity
Children
cholecalciferol
Cigarettes
D2
D3
denosumab
Dentist
Diagnosis
Diet
Dietary Calcium
DXA
Eating Disorder
ergocalciferol
Ethel Siris
European
European Medicines Agency
Falls
Family History
FDA
FIT study
FLEX study
Football
Fortical
Fosamax
Fracture
fracture liaison service
Fracture reduction
fracture risk
Fractures
FRAX
FREEDOM Study
Healthcare Reform
Heart Disease
height
height loss
High-risk
High School
Hip Fracture
Horizon study
Infants
Injection
Institute of Medicine
Jawbone problems
Kaiser Healthy Bones Program
kale
Kidney Stones
Lawsuit
Medicine
Men Osteoporosis Amgen
Merck
Miacalcin
microbiome
Minors
Muscle function
National Bone Health Alliance
NFL
ONJ
Osseor
Osteonecrosis of the Jaw
Osteoporosis
osteoporosis medicine
osteoporosis treatment
Postmenopausal
Postmenopausal woman
prevention
Preventive Services
Prolia
Protelos
Reclast
Risk
romosozumab
Safety
Salt
sclerostin
Screening
Shot
slides
Smoking
Sodium
spine fractures
stadiometer
strontium
strontium citrate
strontium ranelate
Sunscreen
Supplements
tamoxifen
Teenagers
Teens
tips
Tobacco
Trauma
Treatment
Treatment of osteoporosi
turnip greens
Undertreatment
USPSTF
Vitamin D
Vitamin D level
Vitamin D levels
weight
World Osteoporosis Day
yogurt
your story